|
GSK signs a multi-year agreement with BARDA to supply the US government with anthrax treatment
|
22 September 2013 |
|
GSK launches $50 million venture capital fund to invest in pioneering bioelectronic medicines and technologies
|
08 August 2013 |
|
GSK adds to its commitment to GAVI Alliance to help protect millions more children against infectious diseases
|
30 July 2013 |
|
GSK announces US submission for dabrafenib/trametinib combination in metastatic melanoma
|
11 July 2013 |
|
GSK and Save the Children launch $1 million award to discover new healthcare innovations for reducing child deaths
|
30 June 2013 |
|
GSK and Save the Children form unique partnership to save the lives of one million children
|
14 May 2013 |
|
Funding boost for GSK's open innovation research into diseases affecting the developing world
|
05 May 2013 |
|
$500,000 endowment gift from the GlaxoSmithKline Foundation
|
18 March 2013 |
|
ViiV Healthcare announces FDA priority review designation for dolutegravir
|
17 February 2013 |
|
GSK response to news article in The Guardian on UK legal proceedings related to Avandia
|
30 January 2013 |